Tsuyoshi Hirota

20PUBLICATIONS
54CO-AUTHORS
Molecular targetsPlant physiologyCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 27, 2026
An Orally Available Derivative of a Specific CK2 Inhibitor for Regulating Circadian Rhythms and Acute Myeloid Leukemia.

|Dec 24, 2025
Local peptide signalling induces stomatal closure under drought stress.

Akie Shimotohno, Yoshikatsu Matsubayashi, Yujuan Du

|Sep 26, 2025
Targeting Cryptochromes in Chronic Diseases.

Takuro Toda, Tsuyoshi Hirota

|Apr 01, 2025
Advancing clinical response against glioblastoma: Evaluating SHP1705 CRY2 activator efficacy in preclinical models and safety in phase I trials.

Priscilla Chan, Yoshiko Nagai, Qiulian Wu

|Feb 22, 2023
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells.

Christian Borgo, Luca Cesaro, Tsuyoshi Hirota

|Nov 17, 2022
A methylbenzimidazole derivative regulates mammalian circadian rhythms by targeting Cryptochrome proteins.

Moeri Yagi, Simon Miller, Yoshiko Nagai

Pageof 4

Frequent Collaborators

6 joint publications

Ashutosh Srivastava

5 joint publications

Kenichiro Itami

4 joint publications

Ben L Feringa

3 joint publications

Steve A Kay